TNSN95062A1 - NEW DIALKOXY-PYRIDINYLE-BENZIMIDAZOLE DERIVATIVES - Google Patents
NEW DIALKOXY-PYRIDINYLE-BENZIMIDAZOLE DERIVATIVESInfo
- Publication number
- TNSN95062A1 TNSN95062A1 TNTNSN95062A TNSN95062A TNSN95062A1 TN SN95062 A1 TNSN95062 A1 TN SN95062A1 TN TNSN95062 A TNTNSN95062 A TN TNSN95062A TN SN95062 A TNSN95062 A TN SN95062A TN SN95062 A1 TNSN95062 A1 TN SN95062A1
- Authority
- TN
- Tunisia
- Prior art keywords
- compounds
- methyl
- pyridinyle
- dialkoxy
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LES COMPOSES NOUVEAUX OPTIQUEMENT PURS, SOIT, LES COMPOSES ENANTIOMERES SIMPLES (+)-5-CARBOMETHOXY-6-METHYL-2-[[(3,4-DIMETHOXY-2- PYRIDINYL) METHYL] SULFINYL] -1-H- BENZIMIDAZOLE ET (-) -5- CARBOMETHOXY-6-METHYL-2- [[(3,4-DIMETHOXY-2- PYRIDINYL) METHYL] SULFINYL] -1H-BENZIMIDAZOLE, OU DES SELS THERAPEUTIQUEMENT ACCEPTABLES DE CEUX-CI TELS QUE SELS NA+, Mg2+, Li+, K+, Ca2+ ET N+(R4), OU R EST UN GROUPE ALKYLE AVEC 1 A 4 ATOMES DE CARBONE, DES PROCEDES POUR LEUR PREPARATION ET DES PREPARATIONS PHARMACEUTIQUES CONTENANT LES COMPOSES COMME INGREDIENTS ACTIFS, AINSI QUE L'EMPLOI DES COMPOSES DANS DES PREPARATIONS PHARMACEUTIQUES, ET LES INTERMEDIAIRES OBTENUS EN PREPARANT LES COMPOSESTHE OPTICALLY PURE NEW COMPOUNDS, EITHER, THE SIMPLE ENANTIOMERIC COMPOUNDS (+) - 5-CARBOMETHOXY-6-METHYL-2 - [[(3,4-DIMETHOXY-2- PYRIDINYL) METHYL] SULFINYL] -1-H- BENZIMIDAZOLE AND (-) -5- CARBOMETHOXY-6-METHYL-2- [[(3,4-DIMETHOXY-2- PYRIDINYL) METHYL] SULFINYL] -1H-BENZIMIDAZOLE, OR THERAPEUTICALLY ACCEPTABLE SALTS SUCH AS NA + SALTS, Mg2 +, Li +, K +, Ca2 + AND N + (R4), OR R IS AN ALKYL GROUP WITH 1 TO 4 CARBON ATOMS, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE COMPOUNDS AS ACTIVE INGREDIENTS, AS WELL AS THE USE OF THE COMPOUNDS IN PHARMACEUTICAL PREPARATIONS, AND THE INTERMEDIATES OBTAINED BY PREPARING THE COMPOUNDS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9400511 | 1994-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN95062A1 true TNSN95062A1 (en) | 1996-02-06 |
Family
ID=20392945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN95062A TNSN95062A1 (en) | 1994-05-27 | 1994-05-29 | NEW DIALKOXY-PYRIDINYLE-BENZIMIDAZOLE DERIVATIVES |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0712401A1 (en) |
JP (1) | JPH09504557A (en) |
CN (1) | CN1128997A (en) |
AU (1) | AU2633095A (en) |
BR (1) | BR9506235A (en) |
CA (1) | CA2166988A1 (en) |
CZ (1) | CZ24396A3 (en) |
EE (1) | EE9600011A (en) |
FI (1) | FI960367A (en) |
HU (1) | HU9600005D0 (en) |
IL (1) | IL113604A0 (en) |
IS (1) | IS4321A (en) |
MA (1) | MA23563A1 (en) |
NO (1) | NO960268D0 (en) |
PL (1) | PL312692A1 (en) |
TN (1) | TNSN95062A1 (en) |
WO (1) | WO1995032959A1 (en) |
ZA (1) | ZA954125B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9423968D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Resolution |
GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
IL142629A0 (en) * | 1998-11-18 | 2002-03-10 | Astra Ab | Improved chemical process and pharmaceutical formulation |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP2086543A2 (en) | 2006-10-27 | 2009-08-12 | The Curators of the University of Missouri | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same |
JP2011512416A (en) | 2008-02-20 | 2011-04-21 | ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ | Composition comprising a combination of omeprazole and lansoprazole and a buffer and method of using the same |
KR20110079641A (en) | 2008-09-09 | 2011-07-07 | 아스트라제네카 아베 | Method for delivering a pharmaceutical composition to patient in need thereof |
AU2010263304A1 (en) | 2009-06-25 | 2012-02-02 | Astrazeneca Ab | Method for treating a patient at risk for developing an NSAID-associated ulcer |
EP2797600A4 (en) | 2011-12-28 | 2015-09-16 | Pozen Inc | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2083606C (en) * | 1990-06-20 | 2001-08-21 | Arne Elof Brandstrom | Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
DE4035455A1 (en) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | ENANTIOMER SEPARATION |
-
1994
- 1994-05-29 TN TNTNSN95062A patent/TNSN95062A1/en unknown
-
1995
- 1995-05-03 IL IL11360495A patent/IL113604A0/en unknown
- 1995-05-11 CZ CZ96243A patent/CZ24396A3/en unknown
- 1995-05-11 BR BR9506235A patent/BR9506235A/en not_active Application Discontinuation
- 1995-05-11 CA CA002166988A patent/CA2166988A1/en not_active Abandoned
- 1995-05-11 EP EP95921187A patent/EP0712401A1/en not_active Withdrawn
- 1995-05-11 CN CN95190482A patent/CN1128997A/en active Pending
- 1995-05-11 WO PCT/SE1995/000519 patent/WO1995032959A1/en not_active Application Discontinuation
- 1995-05-11 HU HU9600005A patent/HU9600005D0/en unknown
- 1995-05-11 PL PL95312692A patent/PL312692A1/en unknown
- 1995-05-11 EE EE9600011A patent/EE9600011A/en unknown
- 1995-05-11 JP JP8500730A patent/JPH09504557A/en active Pending
- 1995-05-11 AU AU26330/95A patent/AU2633095A/en not_active Abandoned
- 1995-05-19 ZA ZA954125A patent/ZA954125B/en unknown
- 1995-05-26 MA MA23901A patent/MA23563A1/en unknown
-
1996
- 1996-01-17 IS IS4321A patent/IS4321A/en unknown
- 1996-01-23 NO NO960268A patent/NO960268D0/en unknown
- 1996-01-26 FI FI960367A patent/FI960367A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI960367A0 (en) | 1996-01-26 |
IS4321A (en) | 1996-01-17 |
JPH09504557A (en) | 1997-05-06 |
NO960268L (en) | 1996-01-23 |
HU9600005D0 (en) | 1996-03-28 |
NO960268D0 (en) | 1996-01-23 |
IL113604A0 (en) | 1995-08-31 |
CA2166988A1 (en) | 1995-12-07 |
PL312692A1 (en) | 1996-05-13 |
AU2633095A (en) | 1995-12-21 |
MA23563A1 (en) | 1995-12-31 |
BR9506235A (en) | 1997-08-12 |
FI960367A (en) | 1996-01-26 |
EP0712401A1 (en) | 1996-05-22 |
CN1128997A (en) | 1996-08-14 |
WO1995032959A1 (en) | 1995-12-07 |
ZA954125B (en) | 1995-11-27 |
EE9600011A (en) | 1996-04-15 |
CZ24396A3 (en) | 1996-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN95062A1 (en) | NEW DIALKOXY-PYRIDINYLE-BENZIMIDAZOLE DERIVATIVES | |
FR2421889A1 (en) | NEW DERIVATIVES OF THIAZOLIDINECARBOXYLIC-4 ACID USEFUL AS ANTIHYPERTENSIVE MEDICINAL PRODUCTS AND METHODS FOR THEIR PREPARATION | |
MY121192A (en) | New compounds. | |
EG17795A (en) | Process for preparing of 3-substituted 2-oxindole-1-carboxaimes as analgese and anti-inflammatory agents | |
KR930700482A (en) | Neuroprotective Andolone and Related Derivatives | |
HUP9802937A2 (en) | Benzo[g]quuinoline derivatives, pharmaceutical compositions containing them and their use | |
TNSN91049A1 (en) | SUBSTITUTED BENZIMIDAZOLES, PROCESSES FOR THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE | |
IL85988A (en) | 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them | |
BE888052A (en) | NOVEL MORPHOLINO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM | |
FR2438654A1 (en) | 2-METHYL-DIHYDROPYRIDINE COMPOUND, METHODS FOR OBTAINING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | |
FR2397403A1 (en) | NEW DERIVATIVES OF 1-ACYL 2-CYANO-AZIRIDINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | |
KR950005823A (en) | 5-Amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative | |
YU47338B (en) | NEW COMPOUND 4-FLUORO-2 - // (4-METHOXY-2-PYRIDINYL) METHYL / SULPHINYL - 1H-BENZIMIDAZOL AND PROCEDURE FOR ITS PREPARATION | |
IT1196041B (en) | (8S) -8-FLUOROERITROMICINE, THE PROCEDURE FOR THEIR PREPARATION AND FORMULATIONS SUITABLE FOR THE ORAL ADMINISTRATION CONTAINING THE PRODUCTS | |
TNSN95063A1 (en) | NEW SUBSTITUTED BENZIMIDAZOLES | |
FR2440353A1 (en) | NOVEL ARYLETHANOLS, PROCESSES FOR OBTAINING THEM AND THEIR USE AS A MEDICINAL PRODUCT | |
HUP0004058A2 (en) | Compositions and methods for reversibly increasing permeability of biomembranes | |
KR890009912A (en) | Quinoline derivatives and their preparation | |
FR2603587A1 (en) | 2,3,4,5,6,7-HEXAHYDRO-2,7-METHANO-1,5-BENZOXAZONINE (OR -1,4-BENZOXAZONINE) DERIVATIVES, PROCESS FOR THEIR PREPARATION, MEDICAMENTS CONTAINING THEM AND INTERMEDIATE COMPOUNDS | |
AU687023B2 (en) | Use of idazoxan and derivatives thereof in preparing a drug for treating parkinson's disease and its development | |
FR2355839A1 (en) | OPTICALLY ACTIVE DERIVATIVES OF BENZOXAZOLYL-PROPIONIC ACID, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS CONTAINING THEM | |
ES487631A1 (en) | Hexahydro-1,4-oxazepines, process for their preparation and pharmaceutical compositions containing them. | |
FR2506767A1 (en) | HETEROCYCLIC DERIVATIVES OF AMIDOXIMES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
TNSN92073A1 (en) | QUATERNARY AMMONIUM DERIVATIVES OF (+) AND (-) 10- (1-AZABICYCLO [2,2,2] OCT-3-YL-METHYL) -10-H-PHENOTHIAZINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION | |
ES8703441A1 (en) | 6-Oxomorpholine derivatives, process for their preparation, intermediates, and pharmaceutical compositions containing these derivatives. |